Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor‐dependent, transcription‐independent mechanism
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Recruitment to activated tyrosine kinase growth factor receptors of Grb2 and p21(ras) leads to downstream activation of the kinases Raf, MAPK/Erk kinase (Mek) and, subsequently, extracellular signal-regulated kinase (Erk). Activated Erk phosphorylates specific serine residues within cytosolic phospholipase A(2) (PLA(2)), promoting enzyme translocation to membranes and facilitating liberation of arachidonic acid (AA). In the A549 human adenocarcinoma cell line dexamethasone inhibited epidermal growth factor (EGF)-stimulated cytosolic PLA(2) (cPLA(2)) activation and AA release by blocking the recruitment of Grb2 to the activated EGF receptor (EGF-R) through a glucocorticoid receptor (GR)-dependent (RU486-sensitive), transcription-independent (actinomycin-insensitive), mechanism. The dexamethasone-induced block of Grb2 recruitment was parallelled by changes in phosphorylation status and subcellular localization of lipocortin 1 (LC1) and an increase in the amount of the tyrosine phosphoprotein co-localized with EGF-R. Like dexamethasone, peptides containing E-Q-E-Y-V from the N-terminal domain of LC1 also blocked ligand-induced association of Grb2, p21(ras) and Raf. Our results point to an unsuspected rapid effect of glucocorticoids, mediated by occupation of GR but not by changes in gene transcription, which is brought about by competition between LC1 and Grb2 leading to a failure of recruitment off signalling factors to EGF-R
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Binding of glucocorticoids to GR not only activates the receptor, but also liberates accessory proteins that participate in secondary signaling cascades.”
From Corticosteroids (2016) · cites this paper as [38]
In the citing paper
“For example, when released from the inactive GR protein complex, c-Src activates signaling cascades that inhibit phospholipase A2 activity, phosphorylate annexin 1, and impair the release of arachidonic acid38, 39.”
From Corticosteroids (2016) · cites this paper as [38]
Citations
Cites
Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor
Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A., & Connelly, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.695 · Cited by 1,939
cPLA2 is phosphorylated and activated by MAP kinase
Lin, L.-L., Wartmann, M., Lin, A. Y., Knopf, J. L., Seth, A., & Davis, R. J. (1993) · Cell · doi:10.1016/0092-8674(93)90666-e · Cited by 1,849 · cited 1×
“Activated Erk phosphorylates speci®c serine (Ser) residues within cytosolic phospholipase A2 (cPLA2), promoting enzyme translocation to membranes and facilitating liberation of arachidonic acid (AA) (Lin et al., 1993).”
BackgroundDNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068 · cited 1×
“A recent study, for example, showed that, in contrast to the lethal nature of a GR knock-out, mice bearing a mutation of the GR which disabled dimerization, and hence GRE binding, survived (Reichardt et al., 1998).”
ResultTyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
Migliaccio, A., Di Domenico, M., Castoria, G., de Falco, A., Bontempo, P., Nola, E., & Auricchio, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00471.x · Cited by 959 · cited 1×
“Moreover, direct regulation of signalling mechanisms also appears to be a feature of the action of other steroid receptors, such as that for oestradiol (Migliaccio et al., 1996), and other nuclear hormone receptors (Bost et al., 1997).”
BackgroundMolecular Determinants of Glucocorticoid Receptor Function and Tissue Sensitivity to Glucocorticoids
BAMBERGER, C. M., SCHULTE, H. M., & CHROUSOS, G. P. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-3-245 · Cited by 889 · cited 1×
“The unactivated (unligated) GR is retained in the cytoplasm as a multi-protein complex consisting of heat shock proteins (hsp) (Bamberger et al., 1996) and several kinases of the MAPK signalling system, including Src (Pratt, 1998).”
BackgroundHeck, S., Kullmann, M., Gast, A., Ponta, H., Rahmsdorf, H. J., Herrlich, P., & Cato, A. C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06726.x · Cited by 522 · cited 1×
“The inference was that other transcriptional activators such as AP1 and NFkB, which are probably bound by the GR monomer (Heck et al., 1994), play a key role in mediating the action of glucocorticoids.”
BackgroundMultiple components in an epidermal growth factor-stimulated protein kinase cascade
Ahn, N. G., Seger, R., Bratlien, R. L., Diltz, C. D., Tonks, N. K., & Krebs, E. G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64310-1 · Cited by 492
Pratt, W. B. (1998) · Experimental Biology and Medicine · doi:10.3181/00379727-217-44252 · Cited by 447 · cited 12×
“We show here that both GR and Src are rapidly released from the hsp90 complex in A549 cells following treatment by dexamethasone.”
BackgroundInfluentialInvolvement of p21ras in activation of extracellular signal-regulated kinase 2
de Vries-Smits, A. M. M., Burgering, B. M. T., Leevers, S. J., Mar shall, C. J., & Bos, J. L. (1992) · Nature · doi:10.1038/357602a0 · Cited by 387 · cited 1×
“…adapter protein Grb2 and the small GTPase p21ras initiates transduction of the mitogenic signalling mechanisms leading to downstream activation of the kinases Raf, MAPK/Erk kinase (Mek) and, subsequently, extracellular signal-regulated kinase (Erk) (Ahn et al., 1991; de Vries-Smits et al., 1992).”
BackgroundNuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway
Caelles, C., González-Sancho, J. M., & Muñoz, A. (1997) · Genes & Development · doi:10.1101/gad.11.24.3351 · Cited by 334 · cited 1×
“Recently, other groups have implicated Jnk as an important mediator in A549 cell proliferation (Bost et al., 1997) and suggested that there is cross-talk between this pathway and activation of nuclear hormone receptors (Caelles et al., 1997).”
Background
Cited by
Items 301–330 of 330
Signal Transduction Pathways in use of Dexamethasone Implant in the Eye
Sobacı, G. (2015) · SOJ Immunology · doi:10.15226/soji/3/2/00127
“phospholipase-2 enzyme was rapidly inhibited by dexamethasone [31].”
BackgroundLes complications systémiques du syndrome douloureux régional complexe
Schwartzman, R. J., & Grandjean, F. (2012)
Nunes, P. P. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2016.tde-11082016-141151
Grey, A. M. (2012) · TSpace (University of Toronto)
Regulation of the Rat Hepatic NADPH-cytochrome P450 Oxidoreductase by Glucocorticoids
Vonk, A. (2014) · TSpace (University of Toronto)
Kuipa, M. (2019) · Open University of Cape Town (University of Cape Town)
Bijlsma, J. W. J., & Buttgereit, F. (2009) · Elsevier eBooks · doi:10.1016/b978-032305475-1.50042-2
Molecular mechanisms of drugs recommended in COVID-19 treatment
Walczak, K., Makuch‐Kocka, A., & Ziemińska, J. (2020) · Polish Journal of Public Health · doi:10.2478/pjph-2020-0014
Development of Non-Hormonal Steroids for the Treatment of Duchenne Muscular Dystrophy
Partridge, T. A., Reeves, E. K. M., & Diamond, B. (2013)
Estrategias para revertir la inmunosupresión en el fenómeno de tolerancia a endotoxinas
Barbara, R. (2011) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Clobetasol propionate (Dermovate) gives new opportunities in the treatment ofdermatoses
Khlebnikova, A. N. (2010) · Vestnik dermatologii i venerologii · doi:10.25208/vdv991
Behavioral medical epigenetics
Cox, O., & Lee, R. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823928-5.00017-7
Chapman, K. E. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734913466.793557864
Buttgereit, F., Seibel, M. J., & Bijlsma, J. W. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7234-3691-1.00100-8
Immunosuppressive Therapy in Giant Cell Arteritis: Do Steroids Still Reign Supreme?
Zhao, M. Y., Dhanani, U. M., Charoenkijkajorn, C., Pakravan, M., Mortensen, P. W., & Lee, A. G. (2022) · touchREVIEWS in Ophthalmology · doi:10.17925/usor.2022.16.2.85
Frew, A. J., & Corry, D. B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8165-1.00083-6
Adjunctive medications for food-induced anaphylaxis
Burrows, A. G., Davis, A., Hossenbaccus, L., & Ellis, A. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96018-2.00072-9
Effect of ACTH Stimulation on Ischemia-Modified Albumin Levels in vivo
Şahin, N. M., Esen, S., Erdeve, Ş. S., Neşeli̇oğlu, S., Erel, Ö., & Çetinkaya, S. Ç. (2023) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2023.2023-5-22
Kumar, A., DHIRWAN, G., Tangri, P., & TYAGI, Y. (2025) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2025v18i6.54504
Li, Y., Zhang, Y., Wang, X., Yang, Q., Zhou, X., Wu, J., Yang, X., Zhao, Y., Lin, R., Xie, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15145766
IMPACT DE L’HYPERCORTICISME SUR L’AXE GONADOTROPE FEMELLE
Ayrout, M. (2018) · theses.fr (ABES) · doi:10.70675/194a6ff5z99f6z4ef0z800ez5473528e7a30 · Cited by 1
Mallinger, A. (2019) · theses.fr (ABES) · doi:10.70675/8904ae0cz6f0dz40e7z90a0zafaecd1a0523
The role of PRMT5-mediated methylation of steroid receptor in breast Cancer
Pham, T. H. (2022) · theses.fr (ABES) · doi:10.70675/f6e3d282z871dz4ffaz87bazb04f22d60d50 · Cited by 1
Glucocorticoid receptor activity in triple negative breast cancer
Noureddine, L. M. (2022) · theses.fr (ABES) · doi:10.70675/13ab50cfz7edbz4a44z918aza657b9614a4d · Cited by 1
Post-transcriptional glucocorticoid receptor signalling synchronises circadian rhythmsPreprint
Edmondson, A., Zeller, A., Ahlburg, J., Shlamovitz, I., Mihut, A., Beale, A. D., Franco, C., Smith, T. S., Barry, N., Boulanger, J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.12.743743 · Cited by 1
Architect or Destroyer: The Diversity of Glucocorticoid Receptor Signaling Pathways in the Brain
Shkarina, L. N., Khaybullina, R., Primak, A. L., Дмитриевич, Б. К., Станиславович, Д. С., & Karagyaur, M. N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209027
“…(EGF) did not require the nuclear translocation of GR or its genomic effects, but was abolished by an inhibitor of kinases of the SRC family; the authors concluded that this role is performed precisely by the release of SRC, which triggers the phosphorylation of lipocortin 1 (annexin A1) [103].”
InfluentialOutcomes and optimal treatment of patients with Acromegaly.
Ayuk, J. (2010) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 1
THE EFFECT OF DEXAMETHASONE ON IL-33-MEDIATED MAST CELL ACTIVATION
Chernushevich, O. (2015) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/q3fj-0h62
Siachoque-Montañez, H., Ibáñez‐Pinilla, M., & Gamarra, A. I. (2014) · Revista Ciencias de la Salud · doi:10.12804/revsalud12.03.2014.01 · Cited by 3
Micropatterned Surfaces as Tools for the Study of the Rapid Non-Genomic Actions of Steroid Receptors
Cato, A. C. B., Oppong, E. K., & Sekula‐Neuner, S. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1764-4_15
“Some responses are too rapid to be explained by transcriptional activation and protein synthesis and are therefore referred to as non-genomic mechanism [7].”
Background
Metadata
- Authors
- Croxtall, J. D., Choudhury, Q., & Flower, R. J.
- Affiliations
- Queen Mary University of London (GB)
- Corresponding author
- Croxtall, Jamie D
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-05
- Volume
- 130
- Issue
- 2
- Pages
- 289-298
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1572055
- OpenAlex
- W2076179697
- Cited by
- 332
- References
- 42
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 8 · 2022: 6 · 2021: 12 · 2020: 11 · 2019: 12 · 2018: 11 · 2017: 9 · 2016: 12 · 2015: 12 · 2014: 15 · 2013: 18 · 2012: 17
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- glucocorticoids, dexamethasone, epidermal growth factor receptor, Grb2, p21ras, Raf, ERK signaling, cytosolic phospholipase A2, arachidonic acid release, annexin A1, glucocorticoid receptor, receptor tyrosine kinase signaling, A549 cells
- MeSH terms
- Binding, Competitive, Dexamethasone, Enzyme Activation, Glucocorticoids, Humans, Phospholipases A, Phosphorylation, Protein Conformation, Proteins, Receptors, Glucocorticoid, Transcription, Genetic, Tumor Cells, Cultured, Signal Transduction, Annexin A1, MAP Kinase Signaling System, Adaptor Proteins, Signal Transducing, GRB2 Adaptor Protein, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.